Search - tctmd.com

Displaying 281 - 300 of 334

Sort: Relevancy | Date

Presentation TCT 2015

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Clopidogrel and Prasugrel (DAPT Trial)!

Presenter: C. Michael Gibson, Marco Valgimigli, Robert W. Yeh

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Presenter: Stephen G. Ellis, John A. Ormiston, Tullio Palmerini

October 11, 2015

Presentation TCT 2015

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Presenter: Stephen G. Ellis, John A. Ormiston, Robert A. Byrne

October 11, 2015

Presentation

Left Main or Proximal LAD (LM-pLAD) Coronary Artery Disease Location Identifies High-Risk Pts Deriving Potentially Greater Benefit From Prolonged Dual Antiplatelet Therapy (DAPT)

Presenter: F. Costa

August 21, 2015

Presentation Fellows 2015

Case 2

Presenter: Roxana Mehran, David J. Cohen, Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

Case 1

Presenter: Roxana Mehran, David J. Cohen, Robert W. Yeh

May 15, 2015

Presentation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Presenter: E.J. Armstrong

April 22, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Presentation

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

Presenter: T. Palmerini

March 18, 2015

Presentation

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Presenter: Martine Gilard

March 10, 2015

Presentation

Conflicting Results Between RCTs and Observational Studies on the Impact of PPIs on Cardiovascular Events When Coadministered With DAPT

Presenter: Chiara Melloni

January 25, 2015

Presentation

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Presenter: Antonio Colombo

November 10, 2014

Presentation TCT 2014

Time to Move to 3-6 Months Even in ACS!

Presenter: Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Definitely Not the Data are Clear!

Presenter: Germano Di Sciascio

September 14, 2014

Presentation TCT 2014

Definitely the Data are Clear!

Presenter: E. Magnus Ohman

September 14, 2014

Presentation TCT 2014

No: The Duration of DAPT with All DES Is Still Up in the Air!

Presenter: Laura Mauri

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

Presenter: Fausto Feres

September 14, 2014

Presentation TCT 2014

TCT 3: A Randomized Comparison of Drug-Eluting vs Bare Metal Stenting in Patients with Non-ST Elevation Myocardial Infarction: Results of the ELISA-3 Angiographic Substudy

Presenter: Wouter Remkes, MD

September 14, 2014

Presentation TCT 2014

Not So Fast: Only a Hypothesis has Been Generated!

Presenter: Ajay J. Kirtane

September 14, 2014

Advertisement

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Clopidogrel and Prasugrel (DAPT Trial)!

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? No, This Theoretical Goal Does Not Hold Up Under Scrutiny!

Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal!

Left Main or Proximal LAD (LM-pLAD) Coronary Artery Disease Location Identifies High-Risk Pts Deriving Potentially Greater Benefit From Prolonged Dual Antiplatelet Therapy (DAPT)

Case 2

Case 1

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin

Conflicting Results Between RCTs and Observational Studies on the Impact of PPIs on Cardiovascular Events When Coadministered With DAPT

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Time to Move to 3-6 Months Even in ACS!

Definitely Not the Data are Clear!

Definitely the Data are Clear!

No: The Duration of DAPT with All DES Is Still Up in the Air!

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Yes: The Data from Numerous Randomized Trials and Large Registries are Clear as a Bell!

TCT 3: A Randomized Comparison of Drug-Eluting vs Bare Metal Stenting in Patients with Non-ST Elevation Myocardial Infarction: Results of the ELISA-3 Angiographic Substudy

Not So Fast: Only a Hypothesis has Been Generated!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content